Valion Bio (VBIO) Enterprise Value (2021 - 2026)
Valion Bio (VBIO) posted quarterly Enterprise Value of -$12.6 million for Q4 2025, down 529.37% year-over-year from $2.9 million in Q4 2024, and down 265.22% quarter-over-quarter from -$3.4 million in Q3 2025.
Valion Bio (VBIO) Enterprise Value (2021 - 2026) Analysis & Trends
Valion Bio's Enterprise Value history runs 5 years deep, the most recent figure standing at -$12.6 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 529.37% year-over-year to -$12.6 million; the TTM figure through Dec 2025 stood at -$12.6 million (down 529.37% YoY), while the FY2025 annual figure was -$12.6 million, down 529.37% from the prior year.
- Enterprise Value for Q4 2025 stood at -$12.6 million, down from -$3.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$669000.0 in Q1 2025, with the low at -$12.8 million in Q1 2021.
- The 5-year median for Enterprise Value is -$3.5 million (2022), against an average of -$5.4 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 75.88% in 2023, then sank 529.37% in 2025.
- Valion Bio's Enterprise Value stood at -$12.8 million in 2021, then surged by 72.51% to -$3.5 million in 2022, then rose by 7.79% to -$3.2 million in 2023, then jumped by 38.27% to -$2.0 million in 2024, then tumbled by 529.37% to -$12.6 million in 2025.
- Business Quant data shows VBIO's Enterprise Value at -$12.6 million in Q4 2025, -$3.4 million in Q3 2025, and -$1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | -2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.20 Mn |
| Dec 31, 2025 | -12.60 Mn |
| Sep 30, 2025 | -3.45 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | -669,000.00 |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -3.24 Mn |
| Sep 30, 2023 | -4.74 Mn |
| Jun 30, 2023 | -2.17 Mn |
| Mar 31, 2023 | -5.00 Mn |
| Dec 31, 2022 | -3.52 Mn |
| Sep 30, 2022 | -6.33 Mn |
| Jun 30, 2022 | -9.00 Mn |
| Mar 31, 2022 | -10.34 Mn |
| Dec 31, 2021 | -12.79 Mn |
| Mar 31, 2021 | -12.79 Mn |